| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Blaser K | |
| Akdis CA | |||
| Akdis M | |||
| P2860 | cites work | Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. | Q51699859 |
| T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. | Q52007602 | ||
| The biology and clinical applications of dendritic cells. | Q52185845 | ||
| Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. | Q52592976 | ||
| Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. | Q52904932 | ||
| Expansion of neonatal tolerance to self in adult life: II. Tolerance preferentially spreads in an intramolecular manner. | Q54093234 | ||
| Immunotherapy of allergy: anergy, deletion, and immune deviation | Q56269909 | ||
| Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire | Q56903748 | ||
| Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice | Q56904615 | ||
| ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses | Q56905108 | ||
| Molecular cloning and characterization of a new human histamine receptor, HH4R | Q24290633 | ||
| Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation | Q24291515 | ||
| Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells | Q24538658 | ||
| Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes | Q24673317 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential | Q24680634 | ||
| A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis | Q24683805 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor | Q28144319 | ||
| ICOS co-stimulatory receptor is essential for T-cell activation and function | Q28187985 | ||
| T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma | Q28201095 | ||
| PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2 | Q28202803 | ||
| Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells | Q28207755 | ||
| Expression and function of histamine receptors in human monocyte-derived dendritic cells | Q28216834 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2. | Q30306238 | ||
| Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody | Q31107578 | ||
| Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy | Q31812421 | ||
| Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells | Q33624770 | ||
| Immunological mechanisms operative in allergen-specific immunotherapy | Q33643137 | ||
| IL-13 in allergy: home at last | Q33814921 | ||
| Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases | Q33844486 | ||
| Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model | Q33864389 | ||
| Long-term clinical efficacy of grass-pollen immunotherapy | Q33870492 | ||
| IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway | Q33909853 | ||
| Mechanisms of allergen-specific immunotherapy | Q33945896 | ||
| Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability | Q33963794 | ||
| Immune regulation in atopic dermatitis | Q34096226 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung | Q34118806 | ||
| Hijacking and exploitation of IL-10 by intracellular pathogens | Q34137986 | ||
| Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. | Q34155771 | ||
| Prevention of arthritis by interleukin 10-producing B cells | Q34178104 | ||
| The expanding world of co-stimulation: the two-signal model revisited | Q34198913 | ||
| CD4(+) regulatory T cells | Q34418015 | ||
| Type 1 T regulatory cells. | Q34448429 | ||
| Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation | Q34487760 | ||
| The role of chemokines in linking innate and adaptive immunity | Q34493082 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy? | Q34594992 | ||
| Immune regulation by histamine | Q34987280 | ||
| Novel beta2-adrenergic receptor signaling pathways | Q35016377 | ||
| T cell anergy | Q35019694 | ||
| The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells | Q35026181 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Histamine in the immune regulation of allergic inflammation | Q35171180 | ||
| T cell activation, from atopy to asthma: more a paradox than a paradigm. | Q35197012 | ||
| IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization | Q35757072 | ||
| Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice | Q36362467 | ||
| Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals | Q36362607 | ||
| Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. | Q36362779 | ||
| Models of T cell anergy: is there a common molecular mechanism? | Q36366967 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions | Q36367890 | ||
| The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. | Q36370082 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo | Q36371283 | ||
| Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. | Q36371658 | ||
| CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses | Q36371702 | ||
| Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses | Q36376333 | ||
| Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells | Q36376543 | ||
| Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization | Q36400382 | ||
| Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? | Q40611268 | ||
| Roxatidine- and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice | Q40611576 | ||
| Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine | Q40662562 | ||
| Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis | Q40678149 | ||
| Saying the 'S' word in public. | Q40797288 | ||
| Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 | ||
| Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes | Q40804445 | ||
| IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. | Q40811244 | ||
| T regulatory cells 1 inhibit a Th2-specific response in vivo | Q40846695 | ||
| Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide | Q40908107 | ||
| Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus | Q40976499 | ||
| The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
| Oral tolerance for the treatment of autoimmune diseases | Q41360651 | ||
| Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
| Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production | Q42062033 | ||
| Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells | Q42526048 | ||
| Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin | Q42936502 | ||
| Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
| Histamine induces CD86 expression and chemokine production by human immature dendritic cells | Q43600919 | ||
| Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells | Q43743327 | ||
| Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors | Q43749173 | ||
| IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis | Q43822962 | ||
| Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling | Q44203474 | ||
| IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy | Q44429951 | ||
| Histamine enhances TGF-beta1-mediated suppression of Th2 responses. | Q44457817 | ||
| Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines | Q45889051 | ||
| NK cells regulate CD4 responses prior to antigen encounter. | Q46030093 | ||
| Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Q46925453 | ||
| In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. | Q51696836 | ||
| ??? | Q28185664 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 897-913 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Genes of tolerance | |
| P478 | volume | 59 |
| Q28394353 | 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: farm lifestyles and the hygiene hypothesis |
| Q42957911 | Are we getting enough allergens? |
| Q36169760 | CD4CD25 regulatory T lymphocytes in allergy and asthma |
| Q47913833 | Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. |
| Q40263984 | Dexamethasone and IL-10 stimulate glucocorticoid-induced leucine zipper synthesis by human mast cells. |
| Q99714727 | Evidence for Asthma in the Lungs of Mice Inoculated with Different Doses of Toxocara canis |
| Q34484071 | Immune mechanisms of allergen-specific sublingual immunotherapy |
| Q36273406 | Immunotherapy of hypersensitivity to hymenoptera venom |
| Q36515366 | Mechanisms of allergen specific immunotherapy--T-cell tolerance and more |
| Q37453510 | Mechanisms of immune tolerance to allergens in children |
| Q33834985 | Nanoparticle-allergen complexes for allergen immunotherapy. |
| Q51987507 | New cohorts of naive T cells exacerbate ongoing allergy but can be suppressed by regulatory T cells. |
| Q43569379 | Polyopes affinis alleviates airway inflammation in a murine model of allergic asthma. |
| Q36735354 | Synergistic effect of various regulatory factors in TH1/TH2 balance; immunotherapeutic approaches in asthma |
| Q34012654 | The genetic and environmental basis of atopic diseases |
| Q51575029 | Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children. |
| Q80618997 | [Regulatory cells] |
Search more.